RELEASE OF ANTIINFLAMMATORY MEDIATORS AFTER MECHANICAL TRAUMA CORRELATES WITH SEVERITY OF INJURY AND CLINICAL OUTCOME

被引:100
作者
ERTEL, W
KEEL, M
BONACCIO, M
STECKHOLZER, U
GALLATI, H
KENNEY, JS
TRENTZ, O
机构
[1] UNIV ZURICH,DEPT SURG,DIV TRAUMA SURG,ZURICH,SWITZERLAND
[2] F HOFFMANN LA ROCHE & CO LTD,PHARMACEUT RES,CH-4002 BASEL,SWITZERLAND
[3] SYNTEX RES,INST BIOL RES,PALO ALTO,CA
关键词
D O I
10.1097/00005373-199511000-00011
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Excessive synthesis of proinflammatory cytokines [tumor necrosis factor (TNP)-alpha and interleukin (IL)-1 beta] after trauma has been correlated with poor outcome, Recently, naturally occurring inhibitors of TNF-alpha and IL-1 beta have been characterized such as soluble TNF receptors (sTNFRs) and IL-1 receptor antagonist (IL-1ra), The present study was undertaken to determine whether injury results in a rise of circulating sTNFRs and IL-1ra, If so, whether plasma levels of these anti inflammatory mediators correlate with severity of injury and clinical outcome of these patients, Injured patients (n = 213) showed significantly increased sTNFR and IL-1ra plasma levels throughout the observation period of 14 days, compared with healthy volunteers (n = 127), Patients with severe injury (Injury Severity Score > 16 points) revealed higher levels (p < 0.05) of sTNFRs and IL-1ra than patients with minor trauma (Injury Severity Score less than or equal to 16 points), Patients who died from injury demonstrated increased (p < 0.05) sTNFR p55 and IL-1ra plasma levels, compared with survivors. Thus, anti-inflammatory mechanisms are activated after trauma dependent on severity of injury, Because increased plasma levels of anti-inflammatory reacting proteins portended poorly for patient survival, these mediators may contribute to prediction of outcome after severe injury.
引用
收藏
页码:879 / 887
页数:9
相关论文
共 60 条
[1]   STABILIZATION OF THE BIOACTIVITY OF TUMOR-NECROSIS-FACTOR BY ITS SOLUBLE RECEPTORS [J].
ADERKA, D ;
ENGELMANN, H ;
MAOR, Y ;
BRAKEBUSCH, C ;
WALLACH, D .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (02) :323-329
[2]   A RECOMBINANT HUMAN RECEPTOR ANTAGONIST TO INTERLEUKIN-1 IMPROVES SURVIVAL AFTER LETHAL ENDOTOXEMIA IN MICE [J].
ALEXANDER, HR ;
DOHERTY, GM ;
BURESH, CM ;
VENZON, DJ ;
NORTON, JA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (04) :1029-1032
[3]  
AREND WP, 1991, J IMMUNOL, V147, P1530
[4]   INTERLEUKIN-1 RECEPTOR ANTAGONIST - A NEW MEMBER OF THE INTERLEUKIN-1 FAMILY [J].
AREND, WP .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (05) :1445-1451
[5]   BIOLOGICAL PROPERTIES OF RECOMBINANT HUMAN MONOCYTE-DERIVED INTERLEUKIN-1 RECEPTOR ANTAGONIST [J].
AREND, WP ;
WELGUS, HG ;
THOMPSON, RC ;
EISENBERG, SP .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (05) :1694-1697
[6]  
AREND WP, 1989, J IMMUNOL, V143, P1851
[7]   DIFFERENTIAL ALTERATIONS IN PLASMA IL-L AND TNF LEVELS AFTER TRAUMA AND HEMORRHAGE [J].
AYALA, A ;
WANG, P ;
BA, ZF ;
PERRIN, MM ;
ERTEL, W ;
CHAUDRY, IH .
AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 260 (01) :R167-R171
[8]   INTERLEUKIN-1 INHIBITORY ACTIVITY SECRETED BY A HUMAN MYELOMONOCYTIC CELL-LINE (M20) [J].
BARAK, V ;
TREVES, AJ ;
YANAI, P ;
HALPERIN, M ;
WASSERMAN, D ;
BIRAN, S ;
BRAUN, S .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1986, 16 (11) :1449-1452
[9]   THE ROLE OF THE GUT IN THE DEVELOPMENT OF MULTIPLE ORGAN DYSFUNCTION IN CARDIOTHORACIC PATIENTS [J].
BAUE, AE .
ANNALS OF THORACIC SURGERY, 1993, 55 (04) :822-829
[10]   THE PATHOGENESIS OF SEPSIS [J].
BONE, RC .
ANNALS OF INTERNAL MEDICINE, 1991, 115 (06) :457-469